Breast Cancer Trial, By Invitation NCT06821490 Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT06821490
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are physically well enough to walk and carry out normal daily activities (based on a standard health scoring system called ECOG, scored 0 or 1).
  • People who have been diagnosed with early-stage breast cancer that is HER2-positive and has spread to the lymph nodes under the arm.
  • People whose breast cancer is either hormone receptor-positive or hormone receptor-negative are both eligible.
  • People who have had the affected lymph node under the arm marked (flagged) for identification purposes.
  • Any number of affected or suspicious lymph nodes at the time of diagnosis is acceptable.
  • People who will be receiving a combination of chemotherapy and anti-HER2 treatment before surgery (called neoadjuvant treatment).
  • People who will have their response to treatment assessed using imaging before surgery takes place.
  • People who have no significant other health conditions, have adequate liver and kidney function, and have no medical reasons preventing them from receiving neoadjuvant treatment, surgery, and radiotherapy.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose breast cancer has been determined to be inoperable (not able to be removed with surgery).
  • People who have been diagnosed with inflammatory breast cancer.
  • People who have not had a biopsy taken from the suspicious lymph node, or who have a cluster of fused lymph nodes under the arm (called axillary conglomerate).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Registry
ClinicalTrials.gov
Start date
30 June 2024
Est. completion
30 January 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Location of the marked lymph node and the sentinel lymph node, and assessment after lymphadenectomy of number of true positives and negatives, sensitivity and specificity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov